Clinical Research Fellow in Radiotherapy on cancer evolution

Ref Number

B04-07764

Professional Expertise

Clinical

Department

UCL BEAMS (B04)

Location

London

Working Pattern

Full time

Salary

See advert text

Contract Type

Fixed-term

Working Type

On site

Available for Secondment

No

Closing Date

25-Sept-2026

JD_Param11

Yes

JD_Param12

Yes

The CRUK City of London Radiation Research Centre (CoL RRC) in the department of Medical Physics and biomedical Engineering at UCL is a Cancer Research UK (CRUK) funded centre. The Centre features an ambitious research programme for radiation oncology and radiation biology. The network, Cancer Research UK RadNet, is the charity’s largest ever investment in radiotherapy research and accelerates the development of advanced radiotherapy techniques, challenging the boundaries of this mainstay treatment through world-first exploratory projects.

The Centre is a world-class hub for cancer biotherapeutics. It brings together researchers from four of the central London Cancer Research UK centres: University College London, King’s College London, Barts / Queen Mary University of London and the Francis Crick Institute. This unique interdisciplinary and collaborative network generates novel innovative therapies, diagnostics and stratification strategies in addition to providing a clinical and translational pipeline for cancer discovery science. This post is funded as part of a CoL Radiation Research Centre programme grant.

This role supports clinical and translational research within the CRUK City of London Radiation Research Programme, investigating cancer evolution, treatment response, and mechanisms of radiotherapy resistance through laboratory-based and computational research approaches.

• You will lead and contribute to research projects, analyse biological specimens and clinical datasets, collaborate with multidisciplinary and international teams.

• Support grant applications and publish findings in high-impact scientific forums.

• Working in a highly collaborative and innovative environment alongside researchers and clinicians at UCL and UCLH.

• Contribute to the Providentia 1000 Project, developing a unique integrated radiotherapy and molecular outcomes database for children and young people.

Appointment will be on either RDPS for resident doctors in a GMC-approved training programme, or to CL7 will be where this role is joined with an existing, separate clinical role the applicant holds, in line with the Follett Principles on joint clinical academic employment.

The role is ideally suited to an oncology trainee with strong research, analytical andcommunication skills who is keen to develop expertise in translational cancer research, precision medicine and radiation oncology.

• 41 days’ holiday (27 days annual leave, 8 bank holidays, 6 closure days)
• Option to purchase 5 additional days’ annual leave
• Defined benefit career average revalued earnings pension scheme (CARE)
• Cycle to work scheme, season ticket loan, and immigration loan
• Relocation support for eligible posts
• On-site nursery and gym
• Enhanced maternity, paternity, and adoption pay
• Staff Support Service (employee assistance programme)
• Discounted medical insurance Full details: UCL Rewards and Benefits

London’s Global University, we know diversity fosters creativity and innovation. We are committed to equality of opportunity, to being fair and inclusive, and to being a place where we all belong.

We particularly encourage applications from candidates underrepresented in UCL’s workforce, including those from Black, Asian and ethnic minority backgrounds, disabled people, and – for Grade 9 and 10 roles – women.

Read more: UCL Equality, Diversity and Inclusion .

Applicants should also familiarise themselves with UCL’s policies on: Prevention of Bullying, Harassment and Sexual Misconduct Policy  and Personal Relationships Policy

Attached documents are available under links. Clicking a document link will initialize its download.